CAS 83864-78-2: Obovatol

Obovatol is a lignan compound, which is a type of secondary metabolite. It is sourced from Magnolia obovata, a tree indigenous to East Asia, particularly Japan and Korea. This compound exhibits its biological activities primarily through modulation of various signaling pathways, including those related to inflammation and oxidative stress. Obovatol's mechanism of action involves the inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and reduction of reactive oxygen species (ROS), which contributes to its anti-inflammatory and neuroprotective effects. The uses and applications of Obovatol are primarily in the field of biomedical research, where it is explored for its potential therapeutic roles. Studies have demonstrated its efficacy in mitigating inflammation and protecting against neurodegeneration, making it a candidate for further investigation in the treatment of conditions such as Alzheimer's disease, Parkinson's disease, and other neuroinflammatory disorders. Additionally, its antioxidative properties may be beneficial in the context of cardiovascular research, where oxidative stress is a known contributing factor to disease pathology.

Obovatol has antioxidant, neuroprotective, antiinflammatory, antithrombotic and antitumour effects, it is a potent NF-κB inhibitors for Alzheimer's disease